<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT02199132</url>
  </required_header>
  <id_info>
    <org_study_id>CPT_ORL14_YE1</org_study_id>
    <nct_id>NCT02199132</nct_id>
  </id_info>
  <brief_title>Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli</brief_title>
  <official_title>Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective study of patients diagnosed with a nasopharyngeal carcinoma included in our&#xD;
      data base care between June 1990 and September 2013.&#xD;
&#xD;
      Our hypothesis is:&#xD;
&#xD;
      Our series of patients with a history of nasopharyngeal carcinoma presents epidemiological,&#xD;
      response rates to the different treatments and survival similar to those described in the&#xD;
      literature&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective study of 50 patients diagnosed with nasopharyngeal carcinoma. The following&#xD;
      variables will be studied: age, sex, toxic habits , associated pathology, patient origin ,&#xD;
      first symptom , duration , histology, stage , second malignancies , recurrences , metastases&#xD;
      , treatments performed , the response thereto and survival.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of Nasopharyngeal Carcinoma Patients</measure>
    <time_frame>1 year after diagnostic</time_frame>
    <description>Describe our population diagnosed nasopharyngeal carcinoma and compared in epidemiology and therapeutic results with those in the literature</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Nasopharyngeal Carcinoma</condition>
  <arm_group>
    <arm_group_label>Nasopharyngeal Carcinoma</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed of Nasopharyngeal Carcinoma at Ear-Nose-Throught Department at&#xD;
        Corporació Sanitària Parc Taulí from 1993 to 2013&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed of Nasopharyngeal Carcinoma at Ear-Nose-Throat Department at&#xD;
             Corporació Sanitària Parc Taulí from 1993 to 2013&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Corporació Sanitària Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>July 23, 2014</study_first_submitted>
  <study_first_submitted_qc>July 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2014</study_first_posted>
  <last_update_submitted>July 31, 2015</last_update_submitted>
  <last_update_submitted_qc>July 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Yolanda Escamilla-Carpintero</investigator_full_name>
    <investigator_title>MD Phd</investigator_title>
  </responsible_party>
  <keyword>Nasopharyngeal Carcinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Nasopharyngeal Carcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT02199132
org study id: CPT_ORL14_YE1
nct id: NCT02199132
lead sponsor: 
has dmc: No
Retrospective study of patients diagnosed with a nasopharyngeal carcinoma included in our
      data base care between June 1990 and September 2013.

      Our hypothesis is:

      Our series of patients with a history of nasopharyngeal carcinoma presents epidemiological,
      response rates to the different treatments and survival similar to those described in the
      literature
Retrospective study of 50 patients diagnosed with nasopharyngeal carcinoma. The following
      variables will be studied: age, sex, toxic habits , associated pathology, patient origin ,
      first symptom , duration , histology, stage , second malignancies , recurrences , metastases
      , treatments performed , the response thereto and survival.
observational model: Case-Only
time perspective: Retrospective
measure: Description of Nasopharyngeal Carcinoma Patients
time frame: 1 year after diagnostic
description: Describe our population diagnosed nasopharyngeal carcinoma and compared in epidemiology and therapeutic results with those in the literature
arm group label: Nasopharyngeal Carcinoma
study pop: 
sampling method: Non-Probability Sample
criteria: 
gender: All
minimum age: N/A
maximum age: N/A
healthy volunteers: No
facility: 
country: Spain
responsible party type: Principal Investigator
investigator affiliation: Corporacion Parc Tauli
investigator full name: Yolanda Escamilla-Carpintero
investigator title: MD Phd
mesh term: Carcinoma
mesh term: Nasopharyngeal Carcinoma